rheumatoid arthritis therapy (EPIcyte)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namerheumatoid arthritis therapy (EPIcyte)
Drug Alias NameTNF-alpha ValidTarget antibody (EPIcyte)Crohns disease therapy (EPIcyte)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsCrohn DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEPIcyte Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEPIcyte Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A